A detailed history of Oppenheimer Asset Management Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 2,175 shares of DGX stock, worth $298,170. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,175
Previous 2,253 3.46%
Holding current value
$298,170
Previous $308,000 3.25%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$137.09 - $137.09 $10,693 - $10,693
-78 Reduced 3.46%
2,175 $298,000
Q2 2024

Aug 08, 2024

BUY
$125.91 - $144.34 $7,554 - $8,660
60 Added 2.74%
2,253 $308,000
Q1 2024

May 06, 2024

SELL
$123.78 - $142.11 $12,006 - $13,784
-97 Reduced 4.24%
2,193 $291,000
Q4 2023

Feb 13, 2024

BUY
$120.62 - $141.12 $276,219 - $323,164
2,290 New
2,290 $315,000
Q4 2022

Feb 06, 2023

SELL
$123.31 - $157.26 $37,609 - $47,964
-305 Reduced 14.91%
1,741 $272,000
Q3 2022

Nov 14, 2022

BUY
$121.77 - $141.1 $4,749 - $5,502
39 Added 1.94%
2,046 $251,000
Q2 2022

Aug 08, 2022

SELL
$127.07 - $145.39 $10,165 - $11,631
-80 Reduced 3.83%
2,007 $268,000
Q1 2022

May 12, 2022

SELL
$129.09 - $164.35 $100,173 - $127,535
-776 Reduced 27.1%
2,087 $286,000
Q4 2021

Feb 02, 2022

SELL
$140.36 - $173.01 $94,743 - $116,781
-675 Reduced 19.08%
2,863 $496,000
Q3 2021

Nov 12, 2021

SELL
$132.95 - $158.0 $50,388 - $59,882
-379 Reduced 9.68%
3,538 $514,000
Q2 2021

Aug 03, 2021

BUY
$126.66 - $141.48 $11,526 - $12,874
91 Added 2.38%
3,917 $516,000
Q1 2021

May 17, 2021

SELL
$114.63 - $133.34 $3,095 - $3,600
-27 Reduced 0.7%
3,826 $491,000
Q4 2020

Feb 11, 2021

SELL
$112.7 - $128.05 $113,150 - $128,562
-1,004 Reduced 20.67%
3,853 $459,000
Q3 2020

Nov 13, 2020

BUY
$107.05 - $130.01 $31,579 - $38,352
295 Added 6.47%
4,857 $556,000
Q2 2020

Aug 11, 2020

SELL
$73.34 - $122.61 $7,994 - $13,364
-109 Reduced 2.33%
4,562 $519,000
Q1 2020

May 08, 2020

BUY
$75.14 - $115.68 $134,350 - $206,835
1,788 Added 62.02%
4,671 $376,000
Q4 2019

Feb 07, 2020

BUY
$100.29 - $107.99 $100 - $107
1 Added 0.03%
2,883 $308,000
Q3 2019

Oct 31, 2019

BUY
$97.85 - $107.42 $1,076 - $1,181
11 Added 0.38%
2,882 $308,000
Q2 2019

Aug 09, 2019

BUY
$85.18 - $101.94 $61,159 - $73,192
718 Added 33.35%
2,871 $292,000
Q1 2019

Apr 24, 2019

BUY
$80.68 - $89.92 $151,920 - $169,319
1,883 Added 697.41%
2,153 $194,000
Q4 2018

Jan 30, 2019

SELL
$79.75 - $108.38 $1.18 Million - $1.61 Million
-14,846 Reduced 98.21%
270 $23,000
Q3 2018

Oct 26, 2018

SELL
$105.42 - $114.99 $65,782 - $71,753
-624 Reduced 3.96%
15,116 $1.63 Million
Q2 2018

Aug 10, 2018

BUY
$97.35 - $113.14 $1.53 Million - $1.78 Million
15,740 New
15,740 $1.73 Million
Q1 2018

May 09, 2018

SELL
$96.42 - $107.88 $414,895 - $464,207
-4,303 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$91.96 - $108.35 $395,703 - $466,230
4,303
4,303 $402,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.